← Back to Patent Explorer
US5429938A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules

Assignee: University of Michigan-Ann Arbor
•
Filing: 1992-03-02
•
Granted: 1995-07-04
•
Expires: 2012-03-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods, including culture media conditions, which provide for isolation and purification of renal tubule stem cells and for in vitro kidney tubulogenesis are disclosed. The methods rely on culturing adult kidney cells in a culture media treated with combinations of transforming growth factor-β 1 , epidermal growth factor, and all-trans retinoic acid.

Inventors

  • 👤 H. David Humes

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:37
CPC Classifications
A; A61; A61K; A61K38/00; C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/0684; C12N5/0687; A61P; A61P13/00; A61P13/02; A61P15/00; C12N5/0686; A61K35/00; A61K35/12; A61K48/00; C12N2501/00; C12N2501/10; C12N2501/11; C12N2501/15; C12N2501/30; C12N2501/38; C12N2501/385; C12N2502/00; C12N2502/28; C12N2510/00; C12N2533/00; C12N2533/50; C12N2533/54; Y; Y10; Y10S; Y10S623/00; Y10S623/915

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 89 words
An ex vivo renal tubule tissue system prepared by a process comprising culturing adult kidney cells in a culture medium comprising all-trans retinoic acid, transforming growth factor-β 1 and either epidermal growth factor or transforming growth factor-α in an amount effective for achieving tubulogenesis, wherein tubulogenesis is a phenotypic transformation of said cells such that condensed aggregates of tubule cells form about a central lumen wherein said lumen is bordered by cells possessing a polarized epithelial phenotype with extensive microvilli formation and tight junctional complexes along the lumenal border.
Claim 2
Dependent Claim 89 words
An ex vivo renal tubule tissue system prepared by a process comprising culturing adult kidney cells in a culture medium comprising all-trans retinoic acid, transforming growth factor-β 1 and either epidermal growth factor or transforming growth factor-α in an amount effective for achieving tubulogenesis, wherein tubulogenesis is a phenotypic transformation of said cells such that condensed aggregates of tubule cells form about a central lumen wherein said lumen is bordered by cells possessing a polarized epithelial phenotype with extensive microvilli formation and tight junctional complexes along the lumenal border.
Claim 3
Dependent Claim 34 words
The renal tubule tissue system of claim 1, wherein said culture medium contains an insoluble factor selected from the group consisting of Type I collagen, Type IV collagen, laminin, proteoglycans, fibronectin, and combinations thereof.
Claim 4
Dependent Claim 32 words
The renal tubule tissue system of claim 1, wherein said culture medium comprises a soluble factor selected from the group consisting of fetal calf serum, prostaglandins, hydrocortisone, triodothyronine, selenium and combinations thereof.
Claim 5
Dependent Claim 54 words
The renal tubule tissue system of claim 1, wherein said culture medium comprises a soluble factor selected from the group consisting of fetal calf serum, prostaglandins, hydrocortisone, triodothyronine, selenium and combinations thereof, and an insoluble factor selected from the group consisting of Type I collagen, Type IV collagen, laminin, proteoglycans, fibronectin, and combinations thereof.
Claim 6
Independent Claim 88 words
A method for growing kidney tubule stem cells ex vivo, comprising culturing adult kidney cells in the presence of all-trans retinoic acid, transforming growth factor-β 1 , and either epidermal growth factor or transforming growth factor-α, in an amount effective for achieving tubulogenesis, wherein tubulogenesis is a phenotypic transformation of said cells such that condensed aggregates of tubule cells form about a central lumen wherein said lumen is bordered by cells possessing a polarized epithelial phenotype with extensive microvilli formation and tight junctional complexes along the lumenal border.
Claim 7
Independent Claim 88 words
A method for growing kidney tubule stem cells ex vivo, comprising culturing adult kidney cells in the presence of all-trans retinoic acid, transforming growth factor-β 1 , and either epidermal growth factor or transforming growth factor-α, in an amount effective for achieving tubulogenesis, wherein tubulogenesis is a phenotypic transformation of said cells such that condensed aggregates of tubule cells form about a central lumen wherein said lumen is bordered by cells possessing a polarized epithelial phenotype with extensive microvilli formation and tight junctional complexes along the lumenal border.
Claim 8
Dependent Claim 31 words
The method of claim 5, wherein said culture medium contains an insoluble factor selected from the group consisting of Type I collagen, Type IV collagen, laminin, proteoglycans, fibronectin, and combinations thereof.
Claim 9
Dependent Claim 29 words
The method of claim 5, wherein said culture medium comprises a soluble factor selected from the group consisting of fetal calf serum, prostaglandins, hydrocortisone, triodothyronine, selenium and combinations thereof.
Claim 10
Dependent Claim 51 words
The method of claim 5, wherein said culture medium contains a soluble factor selected from the group consisting of fetal calf serum, prostaglandins, hydrocortisone, triodothyronine, selenium and combinations thereof, and an insoluble factor selected from the group consisting of Type I collagen, Type IV collagen, laminin, proteoglycans, fibronectin, and combinations thereof.
Claim 11
Independent Claim 90 words
A method for effecting tubulogenesis in a renal cell culture ex vivo, comprising culturing adult kidney cells in the presence of all-trans retinoic acid, transforming growth factor-β 1 , and either epidermal growth factor or transforming growth factor-α in an amount effective for achieving tubulogenesis, wherein tubulogenesis is a phenotypic transformation of said cells such that condensed aggregates of tubule cells form about a central lumen wherein said lumen is bordered by cells possessing a polarized epithelial phenotype with extensive microvilli formation and tight junctional complexes along the lumenal border.
Claim 12
Independent Claim 90 words
A method for effecting tubulogenesis in a renal cell culture ex vivo, comprising culturing adult kidney cells in the presence of all-trans retinoic acid, transforming growth factor-β 1 , and either epidermal growth factor or transforming growth factor-α in an amount effective for achieving tubulogenesis, wherein tubulogenesis is a phenotypic transformation of said cells such that condensed aggregates of tubule cells form about a central lumen wherein said lumen is bordered by cells possessing a polarized epithelial phenotype with extensive microvilli formation and tight junctional complexes along the lumenal border.
Claim 13
Dependent Claim 31 words
The method of claim 9, wherein said culture medium contains an insoluble factor selected from the group consisting of Type I collagen, Type IV collagen, laminin, proteoglycans, fibronectin, and combinations thereof.
Claim 14
Dependent Claim 29 words
The method of claim 9, wherein said culture medium contains a soluble factor selected from the group consisting of fetal calf serum, prostaglandins, hydrocortisone, triodothyronine, selenium and combinations thereof.
Claim 15
Dependent Claim 51 words
The method of claim 9, wherein said culture medium contains a soluble factor selected from the group consisting of fetal calf serum, prostaglandins, hydrocortisone, triodothyronine, selenium and combinations thereof, and an insoluble factor selected from the group consisting of Type I collagen, Type IV collagen, laminin, proteoglycans, fibronectin, and combinations thereof.
Claim 16
Independent Claim 91 words
A method for constructing and maintaining an ex vivo renal tubule tissue system, comprising culturing adult kidney cells in the presence of all-trans retinoic acid, transforming growth factor-β 1 , and either epidermal growth factor or transforming growth factor-α in an amount effective for achieving tubulogenesis, wherein tubulogenesis is aa phenotypic transformation of said cells characterized by condensed aggregates of tubule cells forming about a central lumen wherein said lumen is bordered by cells possessing a polarized epithelial phenotype with extensive microvilli formation and tight junctional complexes along the lumenal border.
Claim 17
Independent Claim 91 words
A method for constructing and maintaining an ex vivo renal tubule tissue system, comprising culturing adult kidney cells in the presence of all-trans retinoic acid, transforming growth factor-β 1 , and either epidermal growth factor or transforming growth factor-α in an amount effective for achieving tubulogenesis, wherein tubulogenesis is aa phenotypic transformation of said cells characterized by condensed aggregates of tubule cells forming about a central lumen wherein said lumen is bordered by cells possessing a polarized epithelial phenotype with extensive microvilli formation and tight junctional complexes along the lumenal border.
Claim 18
Dependent Claim 31 words
The method of claim 13, wherein said culture medium contains an insoluble factor selected from the group consisting of Type I collagen, Type IV collagen, laminin, proteoglycans, fibronectin, and combinations thereof.
Claim 19
Dependent Claim 29 words
The method of claim 13, wherein said culture medium contains a soluble factor selected from the group consisting of fetal calf serum, prostaglandins, hydrocortisone, triodothyronine, selenium and combinations thereof.
Claim 20
Dependent Claim 51 words
The method of claim 13, wherein said culture medium contains a soluble factor selected from the group consisting of fetal calf serum, prostaglandins, hydrocortisone, triodothyronine, selenium and combinations thereof, and an insoluble factor selected from the group consisting of Type I collagen, Type IV collagen, laminin, proteoglycans, fibronectin, and combinations thereof.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-07-03 1999-01-02 1999-07-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-07-03 2003-01-02 2003-07-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-07-03 2007-01-02 2007-07-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag